Menu

Experience

Laura Berezin

    • Kyverna Therapeutics Closes $85 Million Series B 


    • Five Prime Therapeutics Agrees to Sell to Amgen for $1.9 Billion 


    • Ovid - $75 Million IPO 


    • ALX Oncology – $186 Million IPO 


    • Vir Biotechnology - $143 Million IPO 


    • Applied Therapeutics $40 Million IPO 


    • Immune Design Sale to Merck for $300 Million 


    • Harpoon Therapeutics - $76 Million IPO 


    • Kezar Life Sciences – $86 Million IPO